Collegium Pharmaceutical
COLL
NZ$54.12
Share price
-1.45%
Change (1 day)
3.87%
Change (1 year)
Categories
Collegium Pharmaceutical (COLL) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : NZ$2.32 Billion
According to Collegium Pharmaceutical 's latest financial reports the company's total liabilities are NZ$2.32 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Collegium Pharmaceutical - Total liabilities on balance sheet (from 2014 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | NZ$2.54 B | 69.73% |
| 2023-12-31 | NZ$1.49 B | -2.83% |
| 2022-12-31 | NZ$1.54 B | 115.38% |
| 2021-12-31 | NZ$0.71 B | 12.87% |
| 2020-12-31 | NZ$0.63 B | 95.24% |
| 2019-12-31 | NZ$0.32 B | 9.18% |
| 2018-12-31 | NZ$0.29 B | 571.36% |
| 2017-12-31 | NZ$44.33 M | 13.29% |
| 2016-12-31 | NZ$39.13 M | 111.81% |
| 2015-12-31 | NZ$18.47 M | -16.47% |
| 2014-12-31 | NZ$22.11 M | 426.56% |
| 2013-12-31 | NZ$4.2 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Agile Therapeutics
AGRX | NZ$61.37 M | -97.36% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | NZ$6.63 B | 185.46% | 🇮🇪 Ireland |
 United Therapeutics UTHR | NZ$1.55 B | -32.95% | 🇺🇸 USA |
 KemPharm KMPH | NZ$49.46 M | -97.87% | 🇺🇸 USA |